Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07WCT
|
||||
Former ID |
DIB011175
|
||||
Drug Name |
SAR-100842
|
||||
Synonyms |
LPA1/LPA3 antagonist (renal fibrosis), sanofi-aventis
|
||||
Indication | Fibrosis [ICD9: 709.2; ICD10:L90.5] | Phase 2 | [523991] | ||
Company |
Sanofi us
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Lysophosphatidic acid receptor Edg-2 | Target Info | Modulator | [544454] | |
Lysophosphatidate-3 receptor | Target Info | Modulator | [544454] | ||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | LPA receptor mediated eventslysophospholipid_pathway:LPA receptor mediated events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.